Part,  Chapter, Paragraph

  1    I,     2. 10.  4    | interoperability and compatibility. End users are not locked into proprietary
  2   II,     5.  4.  1    |            adequate information for end users is fundamental to empower
  3   II,     5.  5.Int    |            health care and are the main users of inpatient care11,12.
  4   II,     5.  5.Int    |              has been developed to help Users, Carers and families touched
  5   II,     5.  6.  6    |                 complementary medicine. Users and practitioners of complementary
  6   II,     5. 11.  6    |        evaluation should begin with the usersperspective in mind. These
  7   II,     6.Acr        |                Virus~IDU~Injecting Drug Users~LGV~Lymphogranuloma Venereum~
  8   II,     6.  3.  3    |                HIV among injecting drug users (IDU) accounts for a low
  9   II,     6.  3.  4    |            homeless, prisoners and drug users.~ ~TB is more common in
 10   II,     7.Acr        |                Rate~VRU~Vulnerable Road Users~VIP~Violence and Injury
 11   II,     7.  3.  4    |                1.7 million injured road users according to police records
 12   II,     7.  3.  4    |             fatalities and injured road users~ ~More than half of road
 13   II,     7.  3.  4    |                cars but vulnerable road users (pedestrians, cyclists and
 14   II,     7.  3.  4    |                share of vulnerable road users in these absolute figures
 15   II,     7.  4        |             disabled;~· Vulnerable road users;~· Sports injuries;~· Injuries
 16   II,     7.  4.  3    |               Safety of vulnerable road users~ ~Road transport injuries
 17   II,     7.  4.  3    |    Approximately 17 300 vulnerable road users (VRUs: pedestrians, cyclists
 18   II,     7.  4.  3    |      pedestrians, 37% to motorised road users and 17% to cyclists. Approximately
 19   II,     7.  4.  3    |                 million vulnerable road users were injured whereof 1.3
 20   II,     7.  4.  3    |            Mortality of Vulnerable Road Users by road users, EU25~ ~The
 21   II,     7.  4.  3    |           Vulnerable Road Users by road users, EU25~ ~The data presented
 22   II,     7.  4.  3    |             injuries to eulnerable road users in the EU which aims at
 23   II,     7.  4.  3    |               safety of vulnerable road users (pedestrians and two-wheelers)
 24   II,     7.  5        |           disabilities; vulnerable road users; sport injuries; injuries
 25   II,     7.  5        |                 people, vulnerable road users, sport injuries, products
 26   II,     7.  5        |               format and supported by a users' manual (WHO, 2005b).~ ~
 27   II,     7.  6        |               safety of vulnerable road users, and sport safety. Ther
 28   II,     7.  7        |             Injuries to Vulnerable Road Users Including Falls in Pedestrians
 29   II,     7.  7        |                 WHO) (2005b): TEACH-VIP usersmanual. Geneva, World Health
 30   II,     9.  2.  3    |       foreign-born and intravenous drug users. It is also thought that
 31   II,     9.  3.  1    |        healthcare and are the principal users of inpatient care. (Austbury,
 32   II,     9.  3.  1    |              recently, intravenous drug users (IDUs) with an HIV co-infection.~ ~
 33   II,     9.  3.  1    |                amongst intravenous drug users, while a growing proportion
 34   II,     9.  3.  1    |               Atlas~IDUs~Injecting drug users~LOH~Late Onset Hypogonadism~
 35   II,     9.  5.  3    |            healthcare, and are the main users of inpatient care. Gender
 36   II,     9.  5.  3    |            About nine out of 10 tobacco users start before they are 18
 37  III,    10.  2.  1    |               nicotine reported by many users is probably associated to
 38  III,    10.  2.  1    |               pancreatic cancer in snus users (Luo et al, 2007). Other
 39  III,    10.  2.  1    |              the gateway effectsnuff users may later become smokers -
 40  III,    10.  2.  1    |                Virus~IDU~Injecting Drug Users~NSP~Needle and Syringe Programs~
 41  III,    10.  2.  1    |               of long term problem drug users should also be taken into
 42  III,    10.  2.  1    |                and mortality among drug users; (v) demand for drug treatment),
 43  III,    10.  2.  1    |         prevalence and total numbers of users of different drugs in the
 44  III,    10.  2.  1    |                lifetime are not current users anymore. However, last year
 45  III,    10.  2.  1    |              the proportion of cannabis users that go on to more intensive
 46  III,    10.  2.  1    |               or almost daily' cannabis users.~ ~Problem drug use~ ~General
 47  III,    10.  2.  1    |              consisting of problem drug users (PDUs), treatment demands
 48  III,    10.  2.  1    |                  In total, problem drug users estimates from different
 49  III,    10.  2.  1    |             include only injecting drug users (IDUs) and problem opioids
 50  III,    10.  2.  1    |               IDUs) and problem opioids users (POUs), due to various reasons (
 51  III,    10.  2.  1    |           amphetamines/methamphetamines users ranging from 1.55.3 cases
 52  III,    10.  2.  1    |             estimate of problem cocaine users in the range of 3 to 6 per
 53  III,    10.  2.  1    |                 1564.~ ~Problem opioid users and injecting drug users
 54  III,    10.  2.  1    |                users and injecting drug users still remain the main problem
 55  III,    10.  2.  1    |            prevalence of problem opioid users at national level range
 56  III,    10.  2.  1    |                 million) problem opioid users in the EU and Norway. Data
 57  III,    10.  2.  1    |          infectious diseases among drug users. While EU Member States
 58  III,    10.  2.  1    |                including problem opioid users. These general trends were,
 59  III,    10.  2.  1    |         homogenous population of opioid users has been replaced by a more
 60  III,    10.  2.  1    |                including: ageing opioid users who also often use cocaine
 61  III,    10.  2.  1    |          substances, marginalized crack users, socially integrated problem
 62  III,    10.  2.  1    |             cocaine and other stimulant users, intensive cannabis users,
 63  III,    10.  2.  1    |               users, intensive cannabis users, etc. Almost all of these
 64  III,    10.  2.  1    |                of HIV in injecting drug users (IDUs) continued in several
 65  III,    10.  2.  1    |                of IDUs and problem drug users it has been estimated that,
 66  III,    10.  2.  1    |         prevalence among injecting drug usersstudies with national
 67  III,    10.  2.  1    |                2005, all injecting drug users~ ~In recent years, the predominance
 68  III,    10.  2.  1    |         infections among injecting drug users is very widespread with
 69  III,    10.  2.  1    |                of IDUs and problem drug users lead to an estimate of around
 70  III,    10.  2.  1    |         prevalence among injecting drug users, 2004-2005, all injecting
 71  III,    10.  2.  1    |                2005, all injecting drug users~ ~Among the other infections
 72  III,    10.  2.  1    |                    Mortality among drug users12~ ~A multi-country study
 73  III,    10.  2.  1    |               that mortality among drug users is 6-20 times higher for
 74  III,    10.  2.  1(12)|                on the mortality of drug users comes from cohort studies,
 75  III,    10.  2.  1(12)|       generalizable to all problem drug users in the country.~
 76  III,    10.  2.  1    |              long time, particularly in users with predisposing conditions
 77  III,    10.  2.  1    |          doubled. European data on drug users entering treatment for primary
 78  III,    10.  2.  1    |              school drop-outs, cannabis users) and different settings (
 79  III,    10.  2.  1    |           hepatitis B and C) among drug users have triggered the development
 80  III,    10.  2.  1    |                 at least 580 000 opioid users received drug substitution
 81  III,    10.  2.  1    |                  to about 50% of opiate users undergoing such treatment.
 82  III,    10.  2.  1    |             helping former problem drug users to access a job and a home,
 83  III,    10.  2.  1    |      predominantly injectors and opiate users, on the one hand and the
 84  III,    10.  2.  1    |               among many groups of drug users and problem drug users in
 85  III,    10.  2.  1    |             drug users and problem drug users in Europe. Poly–drug use
 86  III,    10.  2.  1    |              population of problem drug users presents multiple health
 87  III,    10.  2.  1    |                 in helping problem drug users or regarding the accessibility
 88  III,    10.  2.  1    |              risk behaviours among drug users, long-term treatment outcomes
 89  III,    10.  2.  1    |            Mortality among problem drug users in Europe: a project of
 90  III,    10.  2.  1    |               and non-injecting cocaine users in Sydney, Australia. Addiction,
 91  III,    10.  3.  1    |              brain tumours in long-term users, with the exception of acoustic
 92  III,    10.  3.  2    |               involvement of downstream users; and better risk communication
 93  III,    10.  3.  2    |                 involve both downstream users and producers for reducing
 94  III,    10.  4.  2    |                the health of consumers, users and of the environment is
 95  III,    10.  5.  1    |                be twofold, with regular users showing higher survival
 96   IV,    11.  2.  1    |               have significantly higher users of outpatient care than
 97   IV,    11.  6.  2    |                introduced to verify the users of health services had paid
 98   IV,    11.  6.  2    |         informal payments among service users highlight the severity of
 99   IV,    12. 10        |                 First Time Noticed Drug Users: FreD” – aimed to discourage
100   IV,    12. 10        |             networking platform of (ex-)users of illegal drugs in co-operation
101   IV,    12. 10        |               Interim National Services Users Executive)~ ~Introduction
102   IV,    12. 10        |                reducing risks for drugs users~2007: inside prevention
103   IV,    12. 10        |            awareness training for drugs users~ Permanent campaign of French